204 related articles for article (PubMed ID: 15086320)
1. Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process.
Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
Haemophilia; 2004 May; 10(3):232-42. PubMed ID: 15086320
[TBL] [Abstract][Full Text] [Related]
2. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates.
Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Thom J; Baker R; Hertzberg M; Street A; Lloyd J; Marsden K;
Lab Hematol; 2005; 11(2):91-7. PubMed ID: 16024332
[TBL] [Abstract][Full Text] [Related]
4. Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program.
Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Baker R; Hertzberg M; Street A; Marsden K
Semin Thromb Hemost; 2006 Jul; 32(5):505-13. PubMed ID: 16862524
[TBL] [Abstract][Full Text] [Related]
5. 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2B VWD.
Favaloro EJ; Bonar R; Meiring M; Street A; Marsden K;
Thromb Haemost; 2007 Aug; 98(2):346-58. PubMed ID: 17721617
[TBL] [Abstract][Full Text] [Related]
6. Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphere.
Favaloro EJ; Bonar R; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
Am J Clin Pathol; 2003 Jun; 119(6):882-93. PubMed ID: 12817437
[TBL] [Abstract][Full Text] [Related]
7. Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification.
Favaloro EJ; Bonar R; Marsden K
Clin Lab Sci; 2008; 21(3):178-83. PubMed ID: 18678140
[TBL] [Abstract][Full Text] [Related]
8. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
Favaloro EJ
Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
[TBL] [Abstract][Full Text] [Related]
10. An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation.
Meijer P; Haverkate F
Semin Thromb Hemost; 2006 Jul; 32(5):485-91. PubMed ID: 16862521
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
14. An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult.
Favaloro EJ
Semin Thromb Hemost; 2007 Nov; 33(8):727-44. PubMed ID: 18175279
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
16. A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
Favaloro EJ; Bukuya M; Martinelli T; Tzouroutis J; Duncan E; Welldon K; Collecutt M; Aumann H; Thom J; Gilmore G
Thromb Haemost; 2002 Mar; 87(3):466-76. PubMed ID: 11916080
[TBL] [Abstract][Full Text] [Related]
17. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey.
Favaloro EJ; Thom J; Baker R;
Blood Coagul Fibrinolysis; 2000 Dec; 11(8):729-37. PubMed ID: 11132651
[TBL] [Abstract][Full Text] [Related]
18. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
19. External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program.
Hayes TE; Brandt JT; Chandler WL; Eby CS; Kottke-Marchant K; Krishnan J; Lefkowitz JB; Olson JD; Rund CR; Van Cott EM; Cunningham MT
Semin Thromb Hemost; 2006 Jul; 32(5):499-504. PubMed ID: 16862523
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
Favaloro EJ
Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
